Evelyn Partners Group Ltd’s Prothena Corp PRTA Stock Holding History

Evelyn Partners Group Ltd’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Buy	+199	New	+$1.97K	﹤0.01%	529

Other funds holding PRTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

DWAM

Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Evelyn Partners Group Ltd's PRTA Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Prothena Corp (PRTA) in Q2 2026: 199 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #529 among its holdings.

69 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

Evelyn Partners Group Ltd held 199 shares of Prothena Corp worth $1.95K as of Q2 2026.
Prothena Corp was a new Evelyn Partners Group Ltd position in Q2 2026.
Prothena Corp made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #529 holding.
69 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.